Lupin and Mylan receive European Marketing Authorization for Nepexto, Biosimilar Etanercept EP News Bureau Jun 4, 2020 A a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to…
